Google Ad

Fujifilm indicators manufacturing contract with U.S. agency VLP for Covid-19 vaccine – Home Health Choices

TOKYO: Fujifilm Holdings Corp mentioned on Thursday that it had signed a producing contract settlement with U.S.-based agency VLP Therapeutics for a Covid-19 vaccine formulation.

Japan’s Fujifilm will use its manufacturing services and infrastructure to deal with improvement of the vaccine for medical trials, the 2 firms mentioned in a press release.

VLP’s RNA-based vaccine candidate was chosen for funding by the Japan Agency for Medical Research and
Development.

The biotech agency has a Japanese subsidiary which is concerned in drug analysis with authorities our bodies and universities.

Fujifilm has been more and more shifting into healthcare over the previous decade from its conventional pictures and workplace options companies.

Last month, it concluded a profitable Phase-Three medical trial of its Avigan drug to be used in Covid-19 sufferers.

A Fujifilm unit can also be concerned in making elements for Novavax Inc’s coronavirus vaccine candidate.

Follow and join with us on , Facebook, Linkedin

Latest Updates

Related Post